Journal Logo

May-June 2008 - Volume 31 - Issue 3
pp: 127-188

Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period: The CoSa Study

Lugaresi, Alessandra; Durastanti, Valentina; Gasperini, Claudio; More

Clinical Neuropharmacology. 31(3):167-172, May-June 2008.